Q4 2021 Allogene Therapeutics Inc Earnings Call Transcript
Hello, and thank you for standing by, and welcome to Allogene Therapeutics Fourth Quarter and Year-End 2021 Conference Call. (Operator Instructions) Please be aware that today's conference call is being recorded.
I would now like to turn the call over to Christine Cassiano, Chief Communications Officer. Ms. Cassiano, please go ahead.
Thank you, operator, and welcome to all who have join this call. After the market closed today, Allogene issued a press release that provides a business update and financial results for the fourth quarter and full year 2021. This press release and today's webcast are both available on our website.
Joining me on the call today are Dr. David Chang, President and Chief Executive Officer; Dr. Rafael Amado, Executive Vice President of Research and Development and Chief Medical Officer; Dr. Eric Schmidt, Chief Financial Officer, and a new voice on our quarterly calls, Dr. Alison Moore, Chief Technical Officer.
During today's call,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |